Our further analysis showed that previously reported homozygous and compound heterozygous mutations in PGM3 were associated with severe immunodeficiency and glycosylation disturbance, while monoallelic mutations were potentially associated with mild phenotypes like IFE, suggesting that PGM3 is potentially a candidate causative gene of epilepsy. The gene discussed is PGM3; the disease is epilepsy.